"DM Hutt"
"WR Skach"
"WE Balch"
"S Noel"
"J Matteson"
"T Okiyoneda"
"PJ Thomas"
"JM Pilewski"
"JW Kelly"
"GL Lukacs"
"JR Riordan"
"M Gentzsch"
"G Manning"
"D Herman"
"EJ Sorscher"
"W Kellner"
"Y Matsumura"
"AP Rodrigues"
"A Schmidt"
"JR_3rd Yates"
"B Hoch"
"RA Frizzell"
"JM Gottesfeld"
Below you will find all the structures identified in the publication. Be warned that this does not imply any activity.
n=4
ID: 21
InChIKey: WAEXFXRVDQXREF-UHFFFAOYSA-N
SMILES: C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
biological descriptors:
CFTR relevance: CFTR proteostasis regulator
Category:
Influence on CFTR function enhances CFTR function
Order of interaction indirect
subcellular compartment several
CID is
5311
synonyms found at PubChem are:
Vorinostat, 149647-78-9, SAHA, suberoylanilide hydroxamic acid, Zolinza, N-hydroxy-N'-phenyloctanediamide, Suberanilohydroxamic acid, N1-hydroxy-N8-phenyloctanediamide, SAHA cpd, MK-0683, MK0683, Vorinostat [USAN], Octanediamide, N-hydroxy-N'-phenyl-, CCRIS 8456, Vorinostat (SAHA, MK0683), N-Hyrdroxy-N'-phenyloctanediamide, Vorinostat MSD, UNII-58IFB293JI, Zolinza (TN), OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE, SHH, N'-hydroxy-N-phenyloctanediamide, CHEMBL98, Vorinostat (JAN/USAN), 58IFB293JI, SKI390, CHEBI:45716, WAEXFXRVDQXREF-UHFFFAOYSA-N, WIN64652, NSC701852, SAHA, Suberoylanilide hydroxamic acid, NSC-701852, NCGC00168085-01, NCGC00168085-02, SW-064652, 8-(hydroxyamino)-8-oxo-N-phenyl-octanamide, Zolinza (TN) (Merck), DSSTox_CID_21133, DSSTox_RID_79632, DSSTox_GSID_41133, N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide, SMR000486344, NHNPODA, CAS-149647-78-9, SR-05000000373, Vorinostat [USAN:INN], vorinostatum, HSDB 7930, 4lxz, N-Hydroxy-N'-phenyl octanediamide, Zolinza; SAHA, Vorinostat (SAHA), Vorinostat - SAHA, MK 0683, 1zz1, Merck brand of Vorinostat, cc-95, D0E7PQ, AC1L1K2K, cid_5311, SCHEMBL9018, Vorinostat (HDAC inhibitor), Suberoylanilidehydroxamic Acid, MLS001065855, MLS006011941, GTPL6852, Zolinza, MK-0683, SAHA, DTXSID6041133, BDBM19149, CTK8B4125, AOB6083, n-hydroxy-n'-phenyl-octanediamide, QCR-121, SUBERANILOHYDROXAMINIC ACID, SYN3006, 1t69, MolPort-003-850-293, N-hydroxy-N''-phenyloctanediamide, BCPP000018, HMS2219L20, HMS3264D20, HMS3327C12, HMS3650D09, HMS3654G11, HMS3715E22, Pharmakon1600-01502267, BCP01858, KS-00000H3B, N1-hydroxy-N8-phenyl-octanediamide, SAHA, >=98% (HPLC), Vorinostat,SAHA,Zolinza,MK-0683, ZINC1543873, Tox21_112605, Tox21_113623, Vorinostat,CAS:149647-78-9, ANW-43951, MFCD00945317, NSC748799, NSC759852, Octanediamide, N1-hydroxy-N8-phenyl, s1047, SK1390, AKOS015966648, Octanediamide, N1-hydroxy-N8-phenyl-, Tox21_112605_1, AC-1923, AN-5256, CCG-208659, CS-0589, DB02546, DG-0025, MCULE-4234367506, NSC-748799, NSC-759852, RP29421, Suberoylanilide hydroxamic acid (SAHA), NCGC00168085-03, NCGC00168085-04, NCGC00168085-05, NCGC00168085-13, BC677687, BP-30216, HY-10221, KB-60639, SC-20040, AB0009911, LS-186548, LS-186997, LS-187780, RT-015807, AM20030018, FT-0082592, FT-0650593, D06320, K-4759, AB00375377-07, AB00375377-08, AB00375377-09, AB01644613_25, 647S789, P111011, Vorinostat, SAHA, suberoylanilide hydroxamic acid, SR-05000000373-2, SR-05000000373-6, SR-05000000373-8, W-201327, BRD-K81418486-001-01-2, BRD-K81418486-001-10-3, BRD-K81418486-001-12-9, BRD-K81418486-001-13-7, BRD-K81418486-001-17-8, BRD-K81418486-001-18-6, Z1541632802
ID: 2932
InChIKey: INVTYAOGFAGBOE-UHFFFAOYSA-N
SMILES: C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3
biological descriptors:
CFTR relevance: CFTR corrector
Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown
CID is
4261
synonyms found at PubChem are:
Entinostat, ms-275, 209783-80-2, SNDX-275, MS 275, MS-27-275, SNDX 275, MS 27-275, Histone Deacetylase Inhibitor I, Entinostat (USAN/INN), Entinostat (MS-275), UNII-1ZNY4FKK9H, 1ZNY4FKK9H, CHEMBL27759, pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate, pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate, INVTYAOGFAGBOE-UHFFFAOYSA-N, MS275, N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide, pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate, Entinostat (MS-275,SNDX-275), IN1470, NSC706995, BAY86-5274, NSC-706995, BAY 86-5274, pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate, pyridin-3-ylmethyl{4-[(2-aminophenyl)carbamoyl]benzyl}carbamate, 3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate, Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester, W-201831, 3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate, N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide, pyridin-3-ylmethyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate, Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester, N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester, 442532-99-2, entinostatum, pyridin-3-ylmethyl (4-((2-aminophenyl)carbamoyl)benzyl)carbamate, N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide, 3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate, PubChem24433, AC1L1HRM, AC1Q5NOI, Entinostat [USAN:INN], MS-275 (Entinostat), MS-275 - Entinostat, D0M8FD, benzamide-type inhibitor, 3, MLS006010183, SCHEMBL148309, GTPL7007, DTXSID0041068, BDBM19410, CTK8F0220, AOB2570, EX-A038, SYN3039, CHEBI:132082, MolPort-005-942-713, BCPP000155, HMS3648K12, HMS3654O11, ACT06782, BCP01824, MS-275,Entinostat,SNDX-275/, ZINC1488870, ABP000145, BN0881, GP3697, s1053, AKOS024262667, AC-8968, AN-1299, BCP9000967, Carbamic acid, 3-pyridinylmethyl ester, CCG-208680, CS-0511, DB11841, Entinostat (MS-275, SNDX-275), RL02591, KS-0000063I, NCGC00165833-01, NCGC00165833-02, NCGC00165833-03, NCGC00165833-04, NCGC00165833-13, AJ-26331, AK158952, AS-17906, BC654076, HY-12163, KB-55107, MS27-275, NCI60_038022, SMR004458705, MS-275, A HDAC1 and HDAC3 inhibitor, AB0021206, AX8140473, KB-302728, LS-185285, RT-013958, ST2406823, FT-0667871, V2451, D09338, W-5370, 48247-EP2298768A1, 48247-EP2305643A1, 48247-EP2308868A1, 48247-EP2311494A1, 48247-EP2311840A1, 783M802, A815057, MS-275,Entinostat, SNDX-275, MS-27-275, SR-01000946382, Entinostat, SNDX-275, MS-27-275, MS-275, SR-01000946382-1, BRD-K77908580-001-02-1, BRD-K77908580-001-04-7, (pyridin-3-yl)methyl 4-(2-aminophenylcarbamoyl)benzylcarbamate, [4-(2-Amino-phenylcarbamoyl)-benzyl]-carbamic acid pyridin-3-ylmethyl ester, N-[[4-[[(2-Aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid, Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester
ID: 3011
InChIKey: RTKIYFITIVXBLE-QEQCGCAPSA-N
SMILES: C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C
biological descriptors:
CFTR relevance: CFTR corrector
Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown
CID is
444732
synonyms found at PubChem are:
trichostatin A, 58880-19-6, Trichostatin A (TSA), TSA, Trichostatin, UNII-3X2S926L3Z, CHEBI:46024, (2E,4E,6R)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide, GNF-PF-1011, RTKIYFITIVXBLE-QEQCGCAPSA-N, 3X2S926L3Z, 2,4-Heptadienamide, 7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-, 7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide, [R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide, Q-201864, Tricostatin A, (2E,4E,6R)-7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE, 2,4-Heptadienamide, 7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-, 2,4-Heptadienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-, TSN, trichostatine a, Trichlostatin A, (2E,4E,6R)-7-(4-dimethylaminophenyl)-4,6-dimethyl-7-oxo-hepta-2,4-dienehydroxamic acid, (2E,4E,6R)-7-(4-Dimethylaminophenyl)-N-hydroxy-4,6-dimethyl-7-oxo-hepta-2,4-dienamide, Trichostatin A,TSA, Trichostatin A/TSA, Antibiotic A-300, (R)-Trichostatin A, NCGC_TSA, 1c3r, 3f0r, Trichostatin-A - TSA, AC1L9GSU, A 300, D0NF6F, SCHEMBL19886, MLS006011095, SGCTO-002, SCHEMBL675951, GTPL7005, DTXSID6037063, CHEBI:93196, MolPort-003-959-819, MolPort-044-724-267, ZX-AFC000233, BCPP000035, HMS1362L09, HMS1792L09, HMS1990L09, HMS3403L09, HMS3649O20, BCP01776, EX-A1665, ABP000141, BDBM50005711, LMPK01000055, MFCD03848392, s1045, Trichostatin A from Streptomyces sp., AKOS015899840, ZINC100014731, A-300-I, CCG-208142, CCG-208681, CS-0499, DB04297, RL04219, NCGC00162453-01, NCGC00162453-02, NCGC00162453-03, NCGC00162453-04, NCGC00162453-05, NCGC00162453-15, 3C10, HY-15144, KB-81257, LS-74195, M984, SC-73346, SMR004702883, A8183, M02571, W-5309, 880T196, SR-05000013796, SR-05000013796-3, BRD-K68202742-001-04-1, BRD-K68202742-001-05-8, I14-11732, Trichostatin A, >=98% (HPLC), from Streptomyces sp., UNII-30RHG284Z4 component RTKIYFITIVXBLE-QEQCGCAPSA-N, Trichostatin A??, Vetec(TM) reagent grade, from Streptomyces sp., >=98%, (2E,4E,6R)-7-(4-dimethylaminophenyl)-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide, (6R)-N-Hydroxy-4,6-dimethyl-7-oxo-7-[4-(dimethylamino)phenyl]-2,4-heptadienamide, (R,2E,4E)-7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide, 7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6R-dimethyl-7-oxo-2E,4E-heptadienamide, 2,4-Heptadienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)- (9CI), 2,4-Heptadienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, [R-(E,E)]-
ID: 2943
InChIKey: JTDYUFSDZATMKU-UHFFFAOYSA-N
SMILES: C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CCCCCC(=O)NO
biological descriptors:
CFTR relevance: CFTR corrector
Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown
CID is
5186
synonyms found at PubChem are:
scriptaid, 287383-59-9, Scriptide, 6-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-hydroxyhexanamide, GCK 1026, GNF-PF-2024, CGK1026, IN1099, 6-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-hexanoic acid hydroxyamide, CHEMBL96051, SB-556629, 6-(1,3-dioxobenzo[de]isoquinolin-2-yl)-N-hydroxyhexanamide, JTDYUFSDZATMKU-UHFFFAOYSA-N, N-Hydroxy-1,3-dioxo-1H-benz(de)isoquinoline-2(3H)-hexan amide, N-Hydroxy-1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-hexanamide, Scriptaid(GCK1026), AC1L1JSF, scriptaid and CGK1026, D0J8OC, AC1Q6JL7, CBDivE_004422, Scriptaid, >=95%, solid, SCHEMBL780490, SCHEMBL780491, GTPL7505, CHEBI:92401, CTK8A6808, KS-00002WSH, DTXSID70274458, MolPort-000-434-144, HMS3269C11, HMS3653D06, 1h-benz[de]isoquinoline-2(3h)-hexanamide, n-hydroxy-1,3-dioxo-, BCP06506, CGK-1026, EX-A1108, ZINC3873638, ANW-62572, BDBM50328678, s8043, SBB039068, STL259803, AKOS000267387, CCG-208690, CS-1014, EG-0074, MCULE-6788459337, QC-8209, NCGC00159564-01, AJ-46378, BAS 00383114, BC600420, HY-15489, AB0097168, AX8233431, KB-144449, RT-015680, FT-0674544, ST45174702, SJ000016636, W-5105, AB00075588-01, SR-01000398526, J-017229, SR-01000398526-1, BRD-K22503835-001-03-7, BRD-K22503835-001-05-2, I14-11722, N-Hydroxy-1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-hexananmide, 6-(1,3-Dioxo-1H, 3H-benzo[de]isoquinolin-2-yl)-hexanoic acid hydroxyamide, 6-(1,3-DIOXO-1H,3H-BENZO[DE]ISOQUINOLIN-2-YL)-N-HYDROXYHEXANAMIDE
Loading…